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Abstract
Background: Today, the medical world faces an increase in the incidence of chronic diseases. Medication adherence is an essential
component of the effective treatment of such diseases and failure to it, especially in the elderly, has a negative impact on health.
Objectives: The current study aimed at determining the level of medication adherence in the elderly with chronic diseases referring
to academic medical centers in Ardabil, Iran.
Methods: In the current cross sectional study, 222 elderly patients with chronic diseases (i e, musculoskeletal, diabetes, cardiovas-
cular and renal conditions) referring to the clinics of Imam Khomeini, Fatemi, and Alavi hospitals in Ardabil in 2018 were selected by
convenience sampling method. Data were collected using a questionnaire including demographic characteristics and the Morisky
medication adherence scale (MMAS). The data were analyzed using descriptive statistics and multivariate logistic regression analysis
with SPSS version 16.
Results: The mean age of the elderly was 68.25± 7.65 years; 187 (84%) subjects had unsatisfactory medication adherence (score < 6)
and only 35 (16%) had a good medication adherence (score > 6). The probability of satisfactory adherence to medication was higher
in the elderly with higher level of education, but other variables such as age, gender, occupational status, income level, network of
life, place of residence, marital status, and type of chronic disease had no significant effect on medication adherence.
Conclusions: The high level of medication non-adherence in the elderly with chronic diseases is a matter of concern and it seems
necessary to perform studies on the barriers to medication adherence in the elderly and solve them.
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1. Background
Population aging is one of the most important demo-
graphic features that comes into prominence in the 21st
century. Aging of the population affects all aspects of the
society including health, social security, education, socio-
cultural activities, and family life (1). In Iran, surveys and
statistical indicators indicate an accelerated growth of the
elderly population. In the census 2016, about 9.3% of the
Iranian population were over 60 years of age (2). Accord-
ing to calculations, by about 2031, an aging explosion will
occur in Iran that drags approximately 20% - 25% of the
population aged 60 and above into poverty (3). As the age
increases, the risk of suffering from one or more chronic
diseases also increases, so that most people over 60 years
old have at least one chronic disease (4). One of the ways to
better manage diseases in the elderly is adherence to treat-
ment regimen. Many patients, especially the ones with
chronic disease, are in trouble to follow medical advices
(5). In addition, mean of medication consumption in the
elderly is higher than other age groups (6). Medication ad-
herence is one of the essential components for the effec-
tive treatment of many diseases (7). Medication compli-
ance is defined as the degree to which patient adheres to
all medical advice provided by the health care providers, as
well as administration and consumption of the prescribed
drugs timely and correctly (8). The World Health Organiza-
tion has adopted the following definition for medication
adherence: “Individual behavior -taking medication, diet,
and/or lifestyle changes- in accordance with recommenda-
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tions from health care providers” (5). Recent studies show
that 55% of elderly people do not follow the medication
regimen prescribed by their physician (9). Overall, medi-
cation adherence is about 50%, and 20% - 25% of prescrip-
tions are never fully implemented. In addition, 20% of pa-
tients take drugs on holidays after filling the prescription,
and frequent forgotten doses are common (7). Therefore,
as a result of poor compliance, patients do not get the most
benefit from their drug therapy. Suboptimal treatment can
lead to increased use of health care services (acute care
and hospitalization), reduced quality of life, and increased
health care costs (drug and medical costs) (5, 10, 11). Physi-
cal impairments and cognitive dysfunctions may increase
the risk for non-adherence in older adults. Poor knowl-
edge about the disease and the reasons why medication is
needed, lack of motivation, low self-efficacy, and substance
abuse are associated with poor medication adherence (12).
However, medication adherence depends on the active par-
ticipation of patients and the voluntary acceptance of their
treatment plans (13). Medication non-adherence remains a
substantial public health problem. Causes of medication
non-adherence are complex and include psychosocial (e g,
alcohol use, depression, and stigma), structural (e g, dis-
tance from clinics, medication costs), therapy-related (e g,
toxicities), and health system–related barriers (e g, lack of
counselling and poor user experience in the health system)
(14). However, educating patients about the importance of
medication adherence, using adherence techniques such
as pillboxes and reminders, and availability of support are
important to promote medication adherence (15-17).
There are many studies on adherence to treatment reg-
imen in the world (18-24), but there are few studies in this
field in Iran and due to the financial burden of chronic dis-
eases on the health and quality of life of the elderly, con-
ducting more studies in this regard seems essential. Most
of the studies examined medication adherence of patients
with a certain disease, particularly diabetes; for the first
time in Iran, researchers aimed at studying medication ad-
herence of elderly people with several types of chronic dis-
eases. Furthermore, determination of the degree of medi-
cation adherence in the elderly with chronic diseases can
provide an opportunity for more systematic planning in
order to increase the improvement of the health and qual-
ity of life in elderly patients.
2. Objectives
The current study aimed at determining the degree of
medication adherence in the elderly with chronic diseases
referring to academic medical centers in Ardabil, Iran.
3. Methods
3.1. Study Design
The current cross sectional study was conducted on
222 elderly people with chronic diseases referring to the
specialized clinics of academic medical centers in Ardabil,
Iran in 2018.
3.2. Sampling
After the approval of the study protocol by the Ethics
Committee of Ardabil University of Medical Sciences and
obtaining the required permissions, the researcher re-
ferred to the specialized clinics of Imam Khomeini, Fatemi,
and Alavi hospitals in Ardabil in order to select the eli-
gible elderly with chronic diseases (i e, musculoskeletal,
diabetes, cardiovascular, and renal conditions) by conve-
nience sampling method. The minimum sample size was
determined 138 using the following sample size formula,
considering the type I error at 0.05.
(1)n =
(
z
1−α/2
)2
× p (1− p)
d2
The prevalence of chronic diseases was 92.2% in the el-
derly (25) and estimated error was 0.05 of the prevalence.
Finally, in order to increase the study power, 222 elderly
people meeting the inclusion criteria- i e, age over 60, hav-
ing chronic disease, and ability to answer questions were
selected. Before distributing the questionnaires, informed
consent was received from all participants and to maintain
anonymity, they were told that it is not necessary to write
their names on the questionnaires. In addition, in case of
semiliterate or illiterate patients, the questionnaires were
filled by the researcher in the interview with each partici-
pant. Patients with a clinical problem during the study, as
well as the ones that did not have the ability to complete
the questionnaire or refrained from completing it were ex-
cluded from the study.
3.3. Instrument
The instrument used in the current study was a two-
part questionnaire. The first part included questions about
the demographic characteristics of individuals as well as
history of chronic diseases. The second part of the ques-
tionnaire was related to the degree of medication adher-
ence for which the Morisky medication adherence scale
(MMAS) (26) was used. The MMAS consists of eight yes/no
questions. In all questions, 1 point is given for each “NO”
answer, except for question 5 where 1 point is given for
the “YES” answer. The total MMAS score is the sum of the
eight questions scores. The total score ranges 0 to 8. In
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the current study, to interpret MMAS scores, total score of
< 6 was considered unsatisfactory medication adherence
(non-adherent), score 6 - 7 as moderate, and score 8 as satis-
factory medication adherence (adherent). The validity and
reliability of MMAS were assessed by Morrisky et al. (27).
3.4. Ethical Considerations
The study protocol was approved by the Ethics Com-
mittee of Ardabil University of Medical Sciences (ethics
code: IR.ARUMS REL-1396-64). Formal permission was ob-
tained from the Ardabil University of Medical Sciences for
the sampling and the implementation of the study. The
study objectives and the method of answering the ques-
tionnaire were explained to participants and written in-
formed consent was obtained from all of them to partici-
pate in the study.
3.5. Data Analysis
The data were analyzed with SPSS version 16 using
descriptive statistics and multivariate logistic regression
analysis. In all cases of analysis, odds ratio was calculated
with 95% confidence interval and P value less than 0.05 was
considered statistically significant. Medication adherence
was distributed to both satisfactory and unsatisfactory de-
grees; that is, medication adherence score 6 was consid-
ered as the cutoff point and logistic regression analysis was
performed on it.
4. Results
The mean± SD age of the elderly in the current study
was 68.25± 7.65 years; ranged 60-94. Other demographic
characteristics of the elderly along with the type of chronic
disease are presented in Table 1. Table 2 shows the fre-
quency of the elderly based on the expressed items of med-
ication adherence.
The distribution of elderly patients referring to Ardabil
academic medical centers according to the degree of med-
ication adherence showed that 187 (84%) elderly patients
had unsatisfactory medication adherence (score < 6), 10
(5%) subjects had moderate (score 6 - 7), and only 25 (11%)
participants had satisfactory medication adherence (score
8). According to logistic regression model, 187 (84%) elderly
patients had unsatisfactory medication adherence (score
< 6) and only 35 (16%) had satisfactory medication adher-
ence (score > 6). Based on the results of the present study,
the items “When you feel like your health concern is under
control, do you sometimes stop taking your medicine?”,
“Have you ever cut back or stopped taking your medica-
tion without telling your doctor, because you felt worse
when you took it?” and “Thinking over the past two weeks,
were there any days when you did not take your health con-
cern medicine?” accounted for the highest percentages, re-
spectively. The lowest percentage (< 50%) of true response
was related to the items “Did you take your health concern
medicine yesterday?” and “Do you ever feel hassled about
sticking to your health concern treatment plan?” respec-
tively (Table 2).
The results of multivariate logistic regression analysis
showed that secondary school, high school, and college
education had a significant and direct effect on the likeli-
hood of satisfactory medication adherence (> 6). On the
other hand, the probability of satisfactory medication ad-
herence in the elderly with secondary school, high school,
and college education compared with the illiterates or
the ones with elementary education was 4.025, 3.220, and
5.257, respectively, which meant that high level of educa-
tion was among the factors that increased the medication
adherence (Table 3). It should be noted that other variables
such as age, gender, occupational status, income level, net-
work of life, place of residence, marital status, and type of
chronic disease had no significant effect on medication ad-
herence.
5. Discussion
According to the current study results, 84% of the el-
derly referring to the specialized clinics of academic med-
ical centers of Ardabil had unsatisfactory medication ad-
herence (score < 6) and only 16% had satisfactory medi-
cation adherence (score > 6). In a study by Rajpura and
Nayak on the factors influencing medication adherence in
the elderly with hypertension, 18.8% of the study partici-
pants had satisfactory medication adherence (28), which
was consistent with the current study results. Also, in the
study by Gholamaliei et al. on medication adherence and
its related factors in patients with type 2 diabetes in Tuy-
serkan city, Iran, results showed that 59.4% of patients had
poor medication adherence (29). The study by Kooshyar
et al. on health literacy and its relationship with medi-
cal adherence and health-related quality of life in diabetic
community-residing elderly in Mashhad, Iran, indicated
that only 12.3% of patients had high medication adherence
and the remaining patients (87.7%) followed their medica-
tion regimen moderately and poorly (30). More studies re-
ported medication non-adherence in patients by 50% (18-
20).
The study by Bezerra et al. showed that 87% of pa-
tients had satisfactory medication adherence (21). In an-
other study by Sweileh et al. on 405 patients with diabetes
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in Nablus, Palestine, approximately 57.3% of the partici-
pants were considered adherent (22). Also, Hochhalter et
al. found that 56% of participants had high medication ad-
herence (23). In a study by Jannuzzi et al. on 100 elderly
outpatients with diabetic retinopathy in Brazil, adherence
to medication therapy was estimated 58% (24). In the study
by Mashrouteh et al. on patients with diabetes in Kerman,
Iran, it was indicated that 74.6% of patients had good com-
pliance (90% and more) with drug regimens (31). Omar
and San in their study on 147 inpatients aged 60 years and
above reported a high medication adherence (66%) (32).
Dashtian et al. also revealed that medication adherence
was good in 76% of patients (33). The controversy in re-
viewed findings might be attributed to different cultural,
social, and economic conditions, or the variety of tools uti-
lized to assess medication adherence.
Based on the current study findings, the item “When
you feel that your health concern is under control, do you
sometimes stop taking your medicine?” accounted for the
highest true response (77.5%); similarly, in the study by
Sweileh et al. 83% of participants gave true responses (no)
to the same item (22). Findings of the study by Omar and
San also supported those of the current study indicating
that only 15.6% of the participants stated that they stopped
taking their medicine when they felt that their problem
was under control (32). Gholamaliei et al. revealed that 30%
of the patients decided to stop taking their medication due
to feeling recovery (29). In addition, in the current study,
68.9% of the participants reported that they did not stop
taking their medication without consulting their doctors;
Sweileh et al. also reported the same results in 83% of pa-
tients (22). In the present study, at least 23.9% of true re-
sponses were related to the item “Did you take your health
concern medicine yesterday?”, but in the study by Sweileh
et al. 91.4% of the participants stated that they received
their medicine yesterday (22).
In the present study, one of the factors related to the de-
gree of medication adherence was the high level of educa-
tion, which meant that high education level was one of the
factors increasing medication adherence. It was in accor-
dance with the findings of the study by Mashrouteh et al.
indicating that the level of education was significantly re-
lated to the level of compliance of patients with drug regi-
mens (31). According to the results of the study by Minaiyan
et al. on 213 patients with asthma, cancer, or kidney trans-
plantation, education level was positively correlated with
adherence to medicines in patients with asthma and the
ones with kidney transplantation, but not in patients with
cancer (34). Other studies by Gholamaliei et al. and Mardby
et al. also indicated a significant correlation between edu-
cation level and compliance with drug regimen (18, 29), but
some investigations did not show any statistically signifi-
cant relationship between education level and medication
adherence (22, 35).
The current study showed that variables such as age,
gender, occupational status, income level, network of life,
place of residence, marital status, and type of chronic dis-
ease had no significant effect on medication adherence.
In consistent with this finding, the study by Mashrouteh
et al. showed no statistically significant relationship be-
tween the level of compliance with drug regimen, and age,
gender, marital status, occupation, and place of residence
(31). Minaiyan et al. found a significant reverse relationship
between age and compliance with drug regimen, but no
significant relationship between gender and compliance
with treatment (34). Alkatheri et al. stated that gender
had a significant correlation with medication adherence;
therefore, males were significantly more likely to be ad-
herent than females (36). Also, Awodele and Osuolale indi-
cated a significant relationship between patient’s age and
gender, and adherence to medication (35). Briesacher et al.
in a study on patients with at least one of the seven medical
conditions showed that the effect of age was different on
drug adherence in patients with various chronic diseases.
For example, in patients with hypertension, drug adher-
ence in the ones aged 70 years and older was higher than
those with lower ages, but adherence was not associated
with age in patients with seizure disorders (37). This con-
troversy in results could be interpreted by the difference
in the disease type or other characteristics of the partici-
pants.
The strength point of the study was that it was con-
ducted on elderly people with several types of chronic dis-
eases; therefore, the results can be generalized to all elderly
patient populations. Also, it addressed a high level of medi-
cation non-adherence in the elderly that some educational
and supportive measures should be taken to promote their
medication adherence. A limitation of the present re-
search was that the data collection was performed through
self-report method, and some people may not answer the
questions correctly and really for some reasons. The re-
sults of the present study indicated that medication non-
adherence in the elderly with chronic diseases is a serious
problem. To control it, preventive measures such as train-
ing on complications and consequences of medication
non-adherence and stopping medication without consult-
ing doctor for elderly patients, training for health care
providers on effective education about timely consump-
tion of drugs to patients and implementation of follow-
up programs for medication adherence of patients with
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Table 1. Demographic Characteristics of the Study Participants and the Type of
Chronic Disease
Variable No. (%)
Gender
Male 116 (52.3)
Female 106 (47.7)
Type of chronic disease
Musculoskeletal 27 (12.1)
Diabetes 63 (28.4)
Cardiovascular 99 (44.6)
Renal 33 (14.9)
Education level
Illiterate or Elementary school 158 (71.2)
Secondary school 24 (10.8)
High school 28 (12.6)
College 12 (5.4)
Marital status
Single 7 (3.1)
Married 182 (82.0)
Divorced 8 (3.6)
Widow 25 (11.3)
Place of residence
Town 147 (66.2)
Village 75 (33.8)
Age group, y
> 70 158 (71.2)
70 - 80 43 (19.4)
> 80 21 (9.4)
Occupational status
Employed 92 (41.4)
Retired 29 (13.1)
Disabled 26 (11.7)
Housekeeper 75 (33.8)
Income level
Very high 6 (2.7)
High 66 (29.7)
Not bad 97 (43.7)
Low 18 (8.1)
Very low 35 (15.8)
Network of life
Alone 12 (5.4)
With spouse 37 (16.7)
With spouse and children 144 (64.8)
With others 29 (13.1)
chronic diseases are essential. It is strongly recommended
that further studies should be conducted regarding barri-
ers to adherence to the drug regimen in the elderly with
chronic diseases in order to take actions for identifying
and removing barriers.
5.1. Conclusions
The high level of medication non-adherence in the el-
derly with chronic diseases and consequences of medica-
tion non-adherence is a matter of concern and it seems nec-
essary to conduct studies to identify the effective factors on
increasing the degree of medication adherence in the el-
derly. It is also important to plan for training on the impor-
tance of medication adherence and possible consequences
of medication cessation without consulting doctor.
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Table 2. Frequency of Participants Based on Items of Medication Adherence
Item Yes No
Do you sometimes forget to take your health concern pills? 106 (47.7) 116 (52.3)
Thinking over the past two weeks, were there any days when you did not take your health concern medicine? 71 (32) 151 (68)
Have you ever cut back or stopped taking your medication without telling your doctor, because you felt worse when you took it? 69 (31.1) 153 (68.9)
When you travel or leave home, do you sometimes forget to bring along your health concern medication? 83 (37.4) 139 (62.6)
Did you take your health concern medicine yesterday? 53 (23.9) 169 (76.1)
When you feel like your health concern is under control, do you sometimes stop taking your medicine? 50 (22.5) 172 (77.5)
Do you ever feel hassled about sticking to your health concern treatment plan? 113 (50.9) 109 (49.1)
Do you sometimes have difficulty remembering to take all of your medicine? 95 (42.8) 127 (57.2)
aValues are expressed as No. (%).
Table 3. Multivariate Analysis of Factors Associated with Medication Adherence
Education Level Medication Adherence
Ba SE Wald P Value OR (95% CI)
Secondary school 1.393 0.528 6.944 0.008 4.025 (1.429 - 11.339)
High school 1.169 0.516 5.126 0.024 3.220 (1.170 - 8.861)
College 1.660 0.683 5.901 0.015 5.257 (1.378 - 20.058)
Abbreviation: SE, standard error.
aB: regression coefficient.
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